Table III.
Maternal gene | SNP500Cancer SNP ID | Chromosome position | Reference haplotype | Variant haplotype | High PAH exposure with reference haplotype (n) | High PAH exposure with variant haplotype (n) | Interaction coefficient (β)a | P |
---|---|---|---|---|---|---|---|---|
Low PAH Exposure with Reference Haplotype (n) | Low PAH Exposure with Variant Haplotype (n) | |||||||
XRCC1 | rs25487 | 44055726 | G | A | 65 | 19 | −0.31 | 0.01 |
rs25489 | 44056412 | G | G | 66 | 21 | |||
Newborn gene | SNP500Cancer SNP ID | Chromosome position | Reference haplotype | Variant haplotype | High PAH exposure with reference haplotype (n) | High PAH exposure with variant haplotype (n) | Interaction coefficient (β)a | P |
Low PAH exposure with reference haplotype (n) | Low PAH exposure with variant haplotype (n) | |||||||
NQO1 | rs10517 | 69743760 | C | C | 59 | 6 | −0.51 | 0.03 |
rs1800566 | 69745145 | C | C | |||||
rs689453 | 69752373 | G | A | 53 | 6 | |||
rs689452 | 69752464 | C | C |
aThe interaction coefficient (β) represents the increase or decrease in the effect of high PAH exposure on the log-transformed level of cord blood B[a]P-DNA adduct formation in the presence of the variant haplotype compared with the effect of high PAH exposure with the reference haplotype.